Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1523, 2006-01, pp. : 11-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ixabepilone indicates activity in difficult-to-treat breast cancers
Inpharma, Vol. 1, Iss. 1561, 2006-01 ,pp. :
INNOVATEive omalizumab therapy effective in difficult-to-treat asthma
Inpharma, Vol. 1, Iss. 1488, 2005-01 ,pp. :
Rituximab reduces joint damage in RA patients
Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. :
Difficult-to-Treat Gouty Arthritis: A Disease Warranting Better Management
Drugs, Vol. 71, Iss. 11, 2011-07 ,pp. :
PML with rituximab during RA treatment
Inpharma, Vol. 1, Iss. 1656, 2008-01 ,pp. :